Hansoh Pharmaceutical Group Co Ltd.
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 --
業務概覽 Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
公司地址 287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
電話號碼 --
傳真號碼 --
公司網頁 https://www.hspharm.com
員工數量 8989
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Huijuan Zhong Chairlady of the Board and Chief Executive Officer -- 28/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Guoqiang Lin Independent Director 28/04/2025
Mr. Sheung Wai Charles Chan Independent Director 28/04/2025
Ms. Huijuan Zhong Chairlady of the Board and Chief Executive Officer 28/04/2025
Dr. Aifeng Lyu Director 28/04/2025
Ms. Yuan Sun Director 28/04/2025
Ms. Dongtao Yang Independent Director 28/04/2025
 
所屬ETF (更新日期: 02/05/2026 02:40)
代號 名稱 佔比% ▼ 持有日期
EQLTiShares MSCI Emerging Mkts Qual Fac ETF0.0001%29/04/2026
NTSEWisdomTree Emerging Mkts Effcnt Cr ETF0.0001%28/04/2026
PCCEPolen Capital China Growth ETF0.0001%31/03/2026
PBEEInvesco PureBeta FTSE Emerging Mkts ETF0.00003%31/05/2023
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%06/03/2026
EMMFWisdomTree Emerging Markets Mltfctr<0.000001%02/04/2026
HAWXiShares Currency Hdgd MSCI ACWI exUS ETF<0.000001%06/03/2026
HEEMiShares Currency Hedged MSCI Em Mkts ETF<0.000001%28/02/2026
  1    2    3   4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.